GoodRx (GDRX) PT Raised to $70 at Cowen on Strong Market Position and an 'Overstated' Amazon Threat

February 12, 2021 11:15 AM EST Send to a Friend
Cowen analyst Charles Rhyee raised the price target on GoodRx (NASDAQ: GDRX) to $70.00 from the prior $50.00 after seeing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login